Cooper, D. S. & Biondi, B. Subclinical thyroid disease. Lancet 379, 1142–1154 (2012).
Jonklaas, J. & Razvi, S. Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers. Lancet Diabetes Endocrinol. 7, 473–483 (2019).
Walsh, J. P. Thyroid function across the lifespan: do age-related changes matter? Endocrinol. Metab. 37, 208–219 (2022).
Hollowell, J. G. et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489–499 (2002).
Article CAS PubMed Google Scholar
Javaid, U., Kennedy, D., Addison, C., Tsatlidis, V. & Razvi, S. Frequency, determinants and costs of thyroid function testing in a laboratory serving a large population. Eur. J. Endocrinol. 186, 553–560 (2022).
Article CAS PubMed Google Scholar
Yamada, S. et al. The impact of age- and sex-specific reference ranges for serum thyrotropin and free thyroxine on the diagnosis of subclinical thyroid dysfunction: a multicentre study from Japan. Thyroid 33, 428–439 (2023).
Article CAS PubMed PubMed Central Google Scholar
Shan, Z. et al. Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: a cross-sectional study in 10 cities. Thyroid 26, 1125–1130 (2016).
Article CAS PubMed Google Scholar
Ehrenkranz, J. et al. Circadian and circannual rhythms in thyroid hormones: determining the TSH and free T4 reference intervals based upon time of day, age, and sex. Thyroid 25, 954–961 (2015).
Article CAS PubMed Google Scholar
Razvi, S. et al. Variation in the reference range limits of thyroid function tests and association with the prevalence of levothyroxine treatment. Eur. J. Endocrinol. 188, K5–K9 (2023).
Taylor, P. N. et al. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. JAMA Intern. Med. 174, 32–39 (2014).
留言 (0)